LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 29 filers reported holding LYRA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $554,438 | +39.4% | 141,800 | +46.5% | 0.01% | +30.0% |
Q2 2023 | $397,848 | +30.9% | 96,800 | -34.1% | 0.01% | +25.0% |
Q1 2023 | $303,876 | -34.1% | 146,800 | 0.0% | 0.01% | -33.3% |
Q4 2022 | $460,952 | +61.7% | 146,800 | +158.0% | 0.01% | +50.0% |
Q3 2022 | $285,000 | -11.2% | 56,900 | 0.0% | 0.01% | +14.3% |
Q2 2022 | $321,000 | +19.3% | 56,900 | -14.9% | 0.01% | +40.0% |
Q1 2022 | $269,000 | -7.9% | 66,900 | 0.0% | 0.01% | 0.0% |
Q4 2021 | $292,000 | -53.7% | 66,900 | -2.9% | 0.01% | -58.3% |
Q3 2021 | $630,000 | +87.5% | 68,900 | +64.4% | 0.01% | +100.0% |
Q2 2021 | $336,000 | -40.8% | 41,900 | -14.5% | 0.01% | -45.5% |
Q1 2021 | $568,000 | +1.6% | 49,000 | 0.0% | 0.01% | -8.3% |
Q4 2020 | $559,000 | – | 49,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. V, L.L.C. | 1,100,852 | $12,550,000 | 16.38% |
Soleus Capital Management, L.P. | 456,138 | $5,199,000 | 0.69% |
Ikarian Capital, LLC | 815,364 | $9,295,000 | 0.41% |
Perceptive Advisors | 3,222,561 | $36,737,000 | 0.39% |
Affinity Asset Advisors, LLC | 50,000 | $570,000 | 0.30% |
RA Capital Management | 815,849 | $9,301,000 | 0.13% |
ArrowMark Colorado Holdings LLC | 775,888 | $8,845,000 | 0.07% |
BOOTHBAY FUND MANAGEMENT, LLC | 87,353 | $996,000 | 0.04% |
Altium Capital Management LP | 5,218 | $59,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 49,000 | $559,000 | 0.01% |